WHO TB-related activities

  WHO Home  - TB HomeWHO Search - Contact

TB Research in TDR   Stop TB Partnership

Global TB Control Report
Country Information
TB Literature
Community Care
DOTS
DOTS Expansion
Drug Resistance and
DOTS-plus
PAL - Practical Approach to Lung health
Public-Private Mix
TB & Gender
TB/HIV
TB in Prisons
 
LINKS
    Stop TB Partnership  
         Global TB Drug Facility (GDF)
    TDR 
EVENTS
  Meeting reports
HOME


Get Acrobat Reader

 

 

 

 

 

TB Literature by Subject

                                                ...scroll down

These lists include a selection of recent articles from refereed journals, book chapters, and other publications on the subject of TB Prevention and Control.  Each list is in alphabetic order by first author.  WHO documents are included at the end of each subject list.

SEARCH 

  • by using the Edit-Find facility in your web browser

  • refereed journals using PubMed

 

View recent WHO TB publications HERE
Catalogue of WHO TB Documents 1998 to present
Catalogue of WHO TB Documents 1988-1997
References:  by Subject
Medline search by WHO TB author
Stop TB Partnership resources

 

 

 


Childhood TB

back to top of the page
back to top

Harries, A.D., Hargreaves, N.J., Graham, S.M., Mwansambo, C., Kazembe, P., Broadhead, R., Maher, D., Salaniponi, F.M.  Childhood tuberculosis in Malawi: nationwide case-finding and treatment outcomes.  International Journal of Tuberculosis and Lung Disease 2002; 6 (5): 424-431.

2003
Adatu F, Odeke R, Mugenyi M, Gargioni G, McCray E, Schneider E, Maher D. Implementation of the DOTS strategy for tuberculosis control in rural Kiboga District, Uganda, offering patients the option of treatment supervision in the community, 1998-1999.  International Journal of Tuberculosis and Lung Disease 2003; 7 (9) Supplement: S63-S71.

Colvin M, Gumede L, Grimwade K, Maher D, Wilkinson D. Contribution of traditional healers to a rural tuberculosis control programme in Hlabisa, South Africa.  International Journal of Tuberculosis and Lung Disease 2003; 7 (9) Supplement: S86-S91.

Dudley L, Azevedo V, Grant R, Schoeman J, Dikweni L, Maher D. Evaluation of community contribution to tuberculosis care in Cape Town, South Africa.  International Journal of Tuberculosis and Lung Disease 2003; 7 (9) Supplement: S48-S55.

Floyd, K., Skeva, J., Nyirenda, T., Gausi, F., and Salaniponi, F.  Cost and Cost-Effectiveness of Increased Community and Primary Care Facility Involvement in Tuberculosis Care in Lilongwe District, Malawi.  International Journal of Tuberculosis and Lung Disease.  2003 Sep; Volume 7, Number 9 Suppl 1: S29-37.

Kangangi J, Kibuga D, Muli J, Maher D, Billo N, Ng’ang’a L, Ngugi E, Kimani V. Decentralization of tuberculosis treatment from the main hospitals to the peripheral health units and the community in Machakos district, Kenya.  International Journal of Tuberculosis and Lung Disease 2003; 7 (9) Supplement: S5-S13

Miti S, Mfungwe V, Reijer P, Maher D. Integration of tuberculosis treatment in a community-based home care programme for persons living with HIV/AIDS in Ndola, Zambia.  International Journal of Tuberculosis and Lung Disease 2003; 7 (9) Supplement: S92-S98.

Moalosi, G., Floyd, K., Phatshwane, J., Moeti, T., Binkin, N., and Kenyon, T.  Cost-Effectiveness of Home-Based Care Versus Hospital Care for Chronically Ill Tuberculosis Patients, Francistown, Botswana.  International Journal of Tuberculosis and Lung Disease.  2003 Sep; Volume 7, Number 9 Suppl 1: S80-5

Nganda, B., Wang'ombe, J., Floyd, K., and Kangangi, J.  Cost and Cost-Effectiveness of Increased Community and Primary Care Facility Involvement in Tuberculosis Care in Machakos District, Kenya.  International Journal of Tuberculosis and Lung Disease.  2003 Sep; Volume 7, Number 9 Suppl 1: S14-20.

Nyirenda T, Harries A, Gausi F, van Gorkom J, Maher D, Floyd K, Salaniponi F. Decentralisation of tuberculosis services in an urban setting, Lilongwe, Malawi. International Journal of Tuberculosis and Lung Disease 2003; 7 (9) Supplement: S21-S28.

Okello, D., Floyd, K., Adatu, F., Odeke, R., and Gargioni, G.  Cost and Cost-Effectiveness of Community-Based Care for Tuberculosis Patients in Rural Uganda.  International Journal of Tuberculosis and Lung Disease.  2003 Sep; Volume 7, Number 9 Suppl 1: S72-9.

Sinanovic E, Floyd K, Dudley L, Azevedo V, Grant R, Maher D. Cost and cost-effectiveness of community-based care for tuberculosis in Cape Town, South Africa.  International Journal of Tuberculosis and Lung Disease 2003; 7 (9) Supplement: S56-S62.

Maher, D.  The role of the community in the control of tuberculosis.  Pages 177-182.   Tuberculosis.  (2003)  Volume 83, Issues 1-3.  Proceedings from the 4th World Congress on Tuberculosis.

2000
Getahun, H., Maher, D. (2000). Contribution of "TB clubs" to tuberculosis control in a rural district in Ethiopia. Int.J.Tuberc.Lung Dis. 4, 174-178.

Hadley, M., Maher, D. (2000). Community involvement in tuberculosis control: lessons from other health care programmes. Int.J.Tuberc.Lung Dis. 4, 401-408

1999
Maher, D.  (1999)  How can communities contribute to TB care?  Health Action 24, 11-12. 
[pdf - 869KB].

Akkslip, S., Rasmithat, S., Maher, D. (1999). Direct observation of tuberculosis treatment by supervised family members in Yasathorn Province, Thailand. Int.J.Tuberc.Lung Dis. 3, 1061-1065.

Maher, D., van Gorkom, J.L., Gondrie, P.C. & Raviglione, M. (1999). Community contribution to tuberculosis care in countries with high tuberculosis prevalence: past, present and future. Int.J.Tuberc.Lung Dis. 3, 762-768.

1997
Maher, D., Hausler, H.P., Raviglione, M.C., Kaleeba, N., Aisu, T., Fourie, B. & Nunn, P. (1997). Tuberculosis care in community care organizations in sub-Saharan Africa: practice and potential. Int.J.Tuberc.Lung Dis. 1, 276-283.
                                                                                                                   [top of list]

WHO Documents (Community Care):  2003/2002/2001/1998/1996/1995
(for information on language(s) available, price where applicable and how to order, click here)

2003
Guidelines for workplace TB Control Activities - The contribution of workplace TB control activities to TB control in the community.  WHO/CDS/TB/2003.323 [pdf - 430KB]

Community contribution to TB care:  practice and policy.  WHO/CDS/TB/2003.312
[pdf - 922KB]

2002
Jaramillo, E.  Community contribution to TB care:  a Latin American perspective.  WHO/CDS/TB/2002.304.  English  [pdf - 57KB];  Contribución de la comunidad a la atención de la tuberculosis:  una perspecitva Latino Americana.  WHO/CDS/TB/2002.304(s).  
Español [pdf - 613KB]

Sharma, B.V.  Community contribution to TB care:  an Asian perspective.      WHO/CDS/TB/2002.302  [pdf - 126KB]

2001
Harries A., Kenyon T., Maher D., Floyd K., Nyarko E., Nkhoma W.  A collaborative project coordinated by WHO. "Community TB care in Africa: Report on a "lessons learned" meeting in Harare, Zimbabwe, 27-29 September 2000.   WHO/CDS/TB/2001.291 [pdf - 145.84KB]

1998 
Maher, D., Kenyon, T. & Floyd, K. (1999). WHO/CDC/USAID Project - "Community TB care in Africa": Interim progress report - Harare, Zimbabwe, 7-9 December 1998. WHO/CDS/CPC/TB/99.263.

1996
WHO/CDC/USAID Community based TB Care Project in Africa: Protocol Development Workshop, Entebbe, Uganda, 11-21 November 1996. WHO/TB/96.219.

Assessment of Tuberculosis Management in Community Care Projects in India. WHO/TB/96.205.

1995 
Assessment of Tuberculosis Management in Community Care Projects in Sub-Saharan Africa (A.74). WHO/TB/95.195.
                                                                                                                   [top of list]

Cost-Effectiveness and Economics of Control
2003/2002/1999/1998/1997/WHO documents

back to top of the page
back to top

2003
Floyd, K.  Costs and effectiveness––the impact of economic studies on TB control, Pages 187-200.   Tuberculosis.  Volume 83, Issues 1-3.  Proceedings from the 4th World Congress on Tuberculosis.

2002
Floyd, K., Blanc, L., Raviglione, M., Lee, J.W.  Resources required for global tuberculosis control.  Science. 2002 Mar 15;295(5562):2040-1.  [Full text]  [Abstract]

1999
Migliori, G.B., Ambrosetti, M., Besozzi, G., Farris, B., Nutini, S., Saini, L., Casali, L., Nardini, S., Bugiani, M., Neri, M. & Raviglione, M.C. (1999). Cost-comparison of different management policies for tuberculosis patients in Italy. AIPO TB Study Group. Bull.World Health Organ. 77, 467-476.

Norval, P.Y., Blomberg, B., Kitler, M.E., Dye, C. & Spinaci, S. (1999). Estimate of the global market for rifampicin-containing fixed-dose combination tablets. Int.J.Tuberc.Lung Dis. 3, S292-S300.

Pathania, V.S., Trnka, L., Krejbich, F. & Dye, C. (1999). A cost-benefit analysis of BCG revaccination in the Czech Republic. Vaccine 17, 1926-1935.

1998
Migliori, G.B., Khomenko, A.G., Punga, V.V., Ambrosetti, M., Danilova, I., Ribka, L.N., Grzemska, M., Sawert, H. & Raviglione, M.C. (1998). Cost-effectiveness analysis of tuberculosis control policies in Ivanovo Oblast, Russian Federation. Ivanovo Tuberculosis Project Study Group. Bull.World Health Organ. 76, 475-483.

1997
Floyd, K., Wilkinson, D. & Gilks, C. (1997). Comparison of cost effectiveness of directly observed treatment (DOT) and conventionally delivered treatment for tuberculosis: experience from rural South Africa. BMJ 315, 1407-1411.

Sawert, H., Kongsin, S., Payanandana, V., Akarasewi, P., Nunn, P.P. & Raviglione, M.C. (1997). Costs and benefits of improving tuberculosis control: the case of Thailand. Soc.Sci.Med. 44, 1805-1816.

Wilkinson, D., Floyd, K. & Gilks, C.F. (1997). Costs and cost-effectiveness of alternative tuberculosis management strategies in South Africa--implications for policy. S.Afr.Med.J. 87, 451-455.
                                                                                                                   [top of list]

WHO Documents (Cost Effectiveness and Economics of Control)
(for information on language(s) available, price where applicable and how to order, click here)

1999
Floyd, K. (1999). Generic protocols for cost and cost-effectiveness analysis of tuberculosis diagnosis and treatment services - Trial edition, Geneva, March 1999. WHO/CDS/CPC/TB/99.261 ([pdf - 5.3MB].

1998
Snyder, C. (1998). Cost savings from new strategies for tuberculosis control in Poland. WHO/TB/98.241 [pdf - 1.34MB].

1996
The Potential Economic Benefits of the DOTS Strategy against TB in India. WHO/TB/96.218 
[pdf - 6.24MB].
                                                                                                                   [top of list]

Diagnosis
2000/1999/1998/WHO documents

back to top of the page
back to top

2000
Banda, H., Harries, A., Boeree, M., Nyirenda, T., Banerjee, A. & Salaniponi, F. (2000). Viability of stored sputum specimens for smear microscopy and culture. Int.J.Tuberc.Lung Dis. 4, 189-284.

Salaniponi, F.M., Harries, A.D., Banda, H.T., Kang, Mphasa, N., Mwale, A., Upindi, B., Nyirenda, T.E., Banerjee, A. & Boeree, M.J. (2000). Care seeking behaviour and diagnostic processes in patients with smear-positive pulmonary tuberculosis in Malawi. Int.J.Tuberc.Lung Dis. 4, 327-332.

1999
Harries, A.D., Nyirenda, T.E., Banerjee, A., Boeree, M.J. & Salaniponi, F.M. (1999). The diagnosis of smear-negative pulmonary tuberculosis: the practice of sputum smear examination in Malawi. Int.J.Tuberc.Lung Dis. 3, 896-900.

Migliori, G.B., Raviglione, M.C., Schaberg, T., Davies, P.D., Zellweger, J.P., Grzemska, M., Mihaescu, T., Clancy, L. & Casali, L. (1999). Tuberculosis management in Europe. Task Force of the European Respiratory Society (ERS), the World Health Organisation (WHO) and the International Union against Tuberculosis and Lung Disease (IUATLD) Europe Region. Eur.Respir.J. 14, 978-992.

Nyirenda, T.E., Harries, A.D., Banerjee, A. & Salaniponi, F.M. (1999). Accuracy of chest radiograph diagnosis for smear-negative pulmonary tuberculosis suspects by hospital clinical staff in Malawi. Trop.Doct. 29, 219-220.

1998
Banda, H., Harries, A., Welby, S., Boeree, M., Wirima, J.J., Subramanyam, V.R., Maher, D., Nunn, P. (1998). Prevalence of tuberculosis in tuberculosis suspects with short duration of cough. Trans Roy Soc Trop Med Hyg. 92, 161-163.

Harries, A.D., Nyirenda, T.E., Banerjee, A., Mundy, C. & Salaniponi, F.M. (1998). District sputum smear microscopy services in Malawi. Int.J.Tuberc.Lung Dis. 2, 914-918.

Schwoebel, V., Perrocheau, A., Veen, J., Rieder, H.L. & Raviglione, M.C. (1998). Improved bacteriological data are needed to give uniform reporting of tuberculosis in Europe [letter]. BMJ 316, 1458.

WHO Documents (Diagnosis):
(for information on language(s) available, price where applicable and how to order, click here)

1998
Foulds, J. (1998). The Tuberculosis Diagnostics Initiative, Geneva, May 1998. WHO/TB/98.249 [pdf - 268KB].

Norval, P. (1998). Laboratory services in tuberculosis control:  Part 1 - Organization and Management, [English, pdf - 580KB] [Russian, pdf - 539KB];  Part 2 - Microscopy, [English, pdf - 1.25MB] [Russian, pdf - 1.28MB]; Part 3 - Culture, [English, pdf - 19MB] [Russian, pdf - 1.3MB].  WHO/TB/98.258.

1994
Paragonimiasis Tuberculosis Diagnostic Confusion: A Review of the Literature, Tuberculosis Programme, WHO, Geneva. WHO/TB/94.181.

DOTS   2003 / WHO documents

back to top of the page
back to top

2003
Dye, C., Watt, C., Bleed, D.M., & Williams, B.G.  What is the limit to case detection under the DOTS strategy for tuberculosis control?  Pages 35-43.  Tuberculosis.  Volume 83, Issues 1-3.  Proceedings from the 4th World Congress on Tuberculosis.

WHO documents (DOTS)  2003/2002/2001/1999
(for information on language(s) available, price where applicable and how to order, click here)

2003
First meeting of the Public-Private Mix - Subgroup for DOTS Expansion WHO/CDS/TB/2003.317 [pdf - 675KB]

Final report of the 3rd DOTS Expansion Working Group Meeting, 5-6 October 2002, Montreal, Canada.  WHO/CDS/TB.2003.315 [pdf - 2MB].

2002
Improving TB drug management:  Accelerating DOTS expansion.  MSH, WHO, Stop TB Partnership.  WHO/CDS/STB/2002.19 [pdf - 2.53MB]

Final Report of the 2nd meeting of the DOTS expansion working group.  31 Oct. 2001, Paris-France.  WHO/CDS/TB/2002.303  [PDF - 126KB]

An Expanded DOTS Framework for effective Tuberculosis Control.  WHO, Geneva.  WHO/CDS/TB/2002.297.  [HTML]

2001
Progress in TB control in high-burden countries, 2001.  One year after the Amsterdam Ministerial Conference.  Global DOTS Expansion Plan.  WHO/CDS/STB/2001.11 [Whole document:  PDF-686.957KB]

1999
Maher, D., Mikulencak, M. (1999). What is DOTS? A guide to understanding the WHO-recommended TB control strategy known as DOTS.  WHO/CDS/CPC/TB/99.270 [
English, pdf - 740KB] [French, pdf - 305KB]

Drug Resistance
2003/2002/
2001/2000/1999/1998/1997/WHO documents

back to top of the page
back to top

2003
Espinal, M.A.. The global situation of MDR-TB.  Pages 44-51.  Tuberculosis.  Volume 83, Issues 1-3.  Proceedings from the 4th World Congress on Tuberculosis.

2002
Dye C, Espinal MA, Watt CJ, Mbiaga C, Williams BG.  Worldwide incidence of multidrug-resistant tuberculosis.  J Infect Dis. 2002 Apr 15;185(8):1197-202.

Dye, C., Williams, B.G., Espinal, M.A. & Raviglione, M.C.  Erasing the world's slow stain:  strategies to beat drug-resistant tuberculosis.  Science.  15 March 2002.  [Abstract] [Full text]

Suarez PG, Floyd K, Portocarrero J, Alarcon E, Rapiti E, Ramos G, Bonilla C, Sabogal I, Aranda I, Dye C, Raviglione M, Espinal MA.  Feasibility and cost-effectiveness of standardised second-line drug treatment for chronic tuberculosis patients: a national cohort study in Peru.
Lancet. 2002 Jun 8;359(9322):1980-9.

2001
Dye, C. & Espinal, M.A. (2001). Will tuberculosis become resistant to all antibiotics? Proc.R.Soc.Lond. 268, 45-52.

Espinal MA. Laszlo A. Simonsen L. Boulahbal F. Kim SJ. Reniero A. Hoffner S. Rieder HL. Binkin N. Dye C. Williams R. Raviglione MC. Global trends in resistance to antituberculosis drugs. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance. New England Journal of Medicine. 344(17):1294-303, 2001 Apr 26.

Espinal MA, Gupta R, Raviglione MC. “The future may not be so dark.” International Journal of Tuberculosis and Lung Disease. 2001; 5(9): 787-788.

Gupta R, Espinal MA, Raviglione MC. “Should programmes invest in second-line treatments for Multidrug-resistant tuberculosis (MDR-TB)?"  International Journal of Tuberuculosis and Lung Disease.  2001;5:1078-79n.

Gupta, R., Kim, J.K., Espinal, M.A., Caudron, J.M., Pecoul, B., Farmer, P.E., Raviglione, M.C., (2001).  Responding to Market Failures in Tuberculosis Control.  Science  293, 1049-1051.

Raviglione MC, Gupta R, Dye C, Espinal MA. “The burden of drug-resistant tuberculosis and mechanisms for its control.” Annals of the New York Academy of Sciences. 2001; 953: 88-96. 

                                                                                                                   [top of list]

2000
Anonymous (2000). Antituberculosis drug resistance worldwide. Wkly Epidemiol.Rec. 75, 93-100.

Dye, C. & Williams, B.G. (2000). Criteria for the control of drug-resistant tuberculosis. Proc.Natl.Acad.Sci.U.S.A. 97, 8180-8185.

Dye, C. & Williams, B.G. (2000). Population dynamics and control of multidrug-resistant tuberculosis. In MDR Mycobacterium Tuberculosis (Portaels, F. and Bastian, I., eds.), Kluwer Academic Publishers, Dortrecht.

Espinal M.A..  Epidemiology of multidrug-resistant tuberculosis in low- and middle-income countries. In: Portaels F and Bastian I.  Multidrug-resistant Tuberculosis. Kluwer Academic Publishers B.V. P. pp 29-44; 2000.

Espinal, M., Kim, S.J., Suarez, P., Kam, K., Khomenko, A.G., Migliori, G.B., Baéz, J., Kochi, A., Dye, C. & Raviglione, M.C. (2000). Standard short-course chemotherapy for drug resistant tuberculosis. Treatment outcomes in six countries. JAMA 283, 2537-2545.
                                                                                                                   [top of list]

1999
Cohn, D.L., Bustreo, F. & Raviglione, M.C. (1997). Drug-resistant tuberculosis: review of the worldwide situation and the WHO/IUATLD Global Surveillance Project. International Union Against Tuberculosis and Lung Disease. Clin.Infect.Dis. 24, S121-S130.

Danilova, I., Stoyunin, M., Repina, E., Vorobiov, M., Adreevna, O., Khomenko, A., Puzanov, V., Kapkov, L., Punga, V., Oswald, G., Afanasiev, N., Carrino, C., Migliori, G., Ambrosetti, M., Maugeri, F., Grzemska, M., Espinal, M., Raviglione, M., Goldfarb, A. & Slutsky, A. (1999). Primary multidrug-resistant tuberculosis - Ivanovo Oblast, Russia, 1999. MMWR Morb.Mortal.Wkly.Rep. 48, 661-663.

Espinal, M.A., Dye, C., Raviglione, M. & Kochi, A. (1999). Rational 'DOTS plus' for the control of MDR-TB. Int.J.Tuberc.Lung Dis. 3, 561-563.

Maher, D., Kibuga, D., Raviglione, M. & Espinal, M. (1999). An African solution? [letter]. Lancet 353, 1530

Raviglione, M.C., Migliori, D.B. & Ambrosetti, M. (1999). La tubercolosi farmacoresistente nel mondo. In La tubercolosi farmacoresistente (Angarano, G., Carbonara, S., Di Pisa, G. and Raviglione, M.C., eds.), Sustems Comunicazioni Edizioni, Vigano di Gaggiano, Milano, Italy.
                                                                                                                   [top of list]

1998
Espinal, M.A., Baez, J., Soriano, G., Garcia, V., Laszlo, A., Reingold, A.L. & Sanchez, S. (1998). Drug-resistant tuberculosis in the Dominican Republic: results of a nationwide survey. Int.J.Tuberc.Lung Dis. 2, 490-498.

Pablos-Mendez, A., Raviglione, M.C. & Nunn, P. (1998). Antituberculosis-drug resistance [letter]. N.Engl.J.Med. 339, 1080-1080.

Pablos-Mendez, A., Raviglione, M.C., Laszlo, A., Binkin, N., Rieder, H.L., Bustreo, F., Cohn, D.L., Lambregts-van Weezenbeek, C.S., Kim, S.J., Chaulet, P. & Nunn, P. (1998). Global surveillance for antituberculosis-drug resistance, 1994-1997. World Health Organization - International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance. N.Engl.J.Med. 338, 1641-1649.

1997
Laszlo, A., Rahman, M., Raviglione, M. & Bustreo, F. (1997). Quality assurance programme for drug susceptibility testing of Mycobacterium tuberculosis in the WHO/IUATLD Supranational Laboratory Network: first round of proficiency testing. Int.J.Tuberc.Lung Dis. 1, 231-238.
                                                                                                                   [top of list]

WHO Documents (Drug Resistance):  2004/2003/2002/2001/2000/1999/1996/1994
(for information on language(s) available, price where applicable and how to order, click here)

2004
Fourth annual meeting of the Stop TB Working Group on DOTS-Plus for MDR-TB
Paris, France 27-28 October 2003
WHO/HTM/TB/2004.341  [pdf - 341KB]

2003
Procurement Manual for the DOTS-plus Projects approved by the Green Light Committee.  Eds. Jouberton, F;  Jaramillo, E (WHO);  and Jille, I;  Wehrens, R;  Sereguina, M (IDA Foundation). WHO/HTM/TB/2003.328 revision 1 [pdf - 103KB].

Guidelines for surveillance of drug resistance in tuberculosis.  Abdel Aziz, M;  Laszlo, A;  Raviglione, M;  Rieder, H;  Espinal, M;  Wright, A.  WHO/CDS/TB/2003.320 [pdf - 357KB].

2002
Gupta, R., Jaramillo, E., Espinal, M. A.  DOTS-Plus:  preliminary results and emerging issues.  Proceedings of the Meeting of the Stop TB Working Group on DOTS-Plus for MDR-TB, Tallinn, Estonia, 10-12 April 2002.  WHO/CDS/TB/2002.307 [PDF - 122KB]

Instructions for applying to the green light committee for access to second-line anti-tuberculosis drugs. (2002)  Gupta et al.  WHO/CDS/TB/2001.286 Rev.1  [PDF - 268.84KB]

2001
Progress in DOTS-Plus and the Management of Multidrug-Resistant Tuberculosis (MDR-TB). Ed. Gupta R, Espinal MA. Geneva, 2001.  WHO/CDS/TB/2001.292  [PDF - 2013.81KB]

Guidelines for drug susceptibility testing for second-line anti-tuberculosis drugs for dots-plus.  WHO/CDS/TB/2001.288 [PDF - 67KB]

2000
Guidelines for establishing DOTS-PLUS pilot projects for the management of multidrug-resistant tuberculosis (MDR-TB). WHO/CDS/TB/2000.279.  In English, French, Russian and Spanish.

Anti-Tuberculosis Drug Resistance in the World - Report No.2, Prevalence and Trends.  The WHO/IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance.  WHO/CDS/TB/2000.278.

DOTS-Plus and the Green Light Committee (Improving access to second-line anti-TB drugs). WHO/CDS/TB/2000.283

Gupta, R., et al. (2000). Procurement of second-line anti-tuberculosis drugs for DOTS-PLUS pilot projects, Cambridge, 5-6 July 1999. WHO/CDS/TB/2000.276.

1999
Espinal, M. (1999). Multidrug resistant tuberculosis (MDR-TB): Basis for the development of an evidence-based case-management strategy for MDR-TB within the WHO's DOTS strategy. WHO/TB/99.260.

Raviglione, M. & Espinal, M. (1999). Coordination of DOTS-PLUS pilot projects for the management of MDR-TB - Proceedings of a Meeting, Geneva, 29 January 1999. WHO/CDS/CPC/TB/99.262.

1997
Raviglione, M. (1997). Anti-Tuberculosis Drug Resistance in the World. The WHO/IUATLD Global Project on Anti-tuberculosis Drug Resistance Surveillance 1994-1997. WHO/TB/97.229.

                                                                                                                   [top of list]

1996
Guidelines for Surveillance of Drug resistance in Tuberculosis. WHO/TB/96.216.

Crofton, J., Chaulet, P., Maher, D. Guidelines on the management of drug-resistant tuberculosis. WHO/TB/96.210  [English, pdf - 315KB] [French, pdf - 302KB] [Spanish, pdf - 569KB].

1994
Guidelines for Surveillance of Drug Resistance in Tuberculosis, Tuberculosis Programme, WHO, Geneva and the International Union Against Tuberculosis and Lung Diseases (IUATLD), Paris (A.72). WHO/TB/94.178 [English, pdf - 720KB [French, pdf - 720KB].

Epidemiology, Surveillance and Control
2004/2003/2001/2000/1999/1998/1997/WHO documents

back to top of the page
back to top

2004
China Tuberculosis Control Collaboration (2004).  The impact of tuberculosis control in China.  Lancet 364, 417-422.

Dye, C. (2004). A booster for tuberculosis vaccines.  JAMA, 291(17):2127-2128.

Espinal, M., and Raviglione, M.  Global Epidemiology of Tuberculosis.  Chapter 3 of the book entitled:  Tuberculosis.  (Edited by Madkour, MM.) (2004)  ISBN 3-540-01441-1 Springer.

2003
Dye, C.  (2003)  Epidemiology.  In:  Davies, P.D.O. (ed.), Clinical Tuberculosis, 3rd edition.  Arnold, London, pp. 21-42.

Corbett, Elizabeth L., Watt, Catherine J., Walker, Neff, Maher, Dermot, Williams, Brian G., Raviglione, Mario C., Dye, Christopher.  The Growing Burden of Tuberculosis:  Global Trends and Interactions with the HIV Epidemic.  Arch Intern Med. 2003;163:1009-1021.  (full article)

Dye, C., Watt, C., Bleed, D.M., & Williams, B.G.  What is the limit to case detection under the DOTS strategy for tuberculosis control?  Pages 35-43.  Tuberculosis.  (2003) Volume 83, Issues 1-3.  Proceedings from the 4th World Congress on Tuberculosis.

Raviglione, M.  The TB epidemic from 1992 to 2002.  Pages 4-14.  Tuberculosis.  (2003)  Volume 83, Issues 1-3.  Proceedings from the 4th World Congress on Tuberculosis.

2001
Shilova, M.V. & Dye, C. (2001) The resurgence of tuberculosis in Russia. Philosophical Transactions of the Royal Society of London B 356, 1069-1075.

Suárez, P., Watt, C.J., Alarcon, E., Portocarrero, J., Zavala, D., Canales, R., Luelmo, F., Espinal, M.A. & Dye, C. (2001) The dynamics of tuberculosis in response to 10 years of intensive control effort in Peru. Journal of Infectious Diseases 184, 473-478.

2000
Bleed, D., Dye, C. & Raviglione, M.C. (2000). Dynamics and control of the global tuberculosis epidemic. Curr.Opin.Pulm.Med 6, 174-179.

Dye, C., Zhao, F., Scheele, S. & Williams, B.G. (2000). Evaluating the impact of tuberculosis control: number of deaths prevented by short-course chemotherapy in China. Int.J.Epidmiol. 29, 558-564.

Maher, D., Kibuga, D., Raviglione, M. & Espinal, M. (1999). An African solution? [letter]. Lancet 353, 1530

Maher, D. & Raviglione, M.C. (1999). The global epidemic of tuberculosis. In Tuberculosis and Non-Tuberculosis Mycobacterial Infections (Schlossberg, D., ed.), W.B. Saunders Company, Philadelphia, PA, USA, pp. 104-115.

Nunn P. (2000) The Global Epidemic, the present epidemiology of tuberculosis. Scottish Medical Journal 45; (supplement 1): 6-7.
                                                                                                                   [top of list]

1999
Drobniewski, F. & Raviglione, M.C. (1999). Epidemiology of tuberculosis in adults within industrialized countries. In Les Médicaments de la Tuberculose chez l'enfant. Comptes Rendus de la Neuvième Journée de Pharmacologie Clinique Pédiatrique, Hôpital Saint-Vincent de Paul, Paris, 20 novembre 1998 (Pons, G., Gendrel, D. and Grosset, J., eds.), Springer-Verlag, Paris, pp. 11-22.

Dye, C. (1999). What can be done to stop the global threat of tuberculosis? A WHO perspective. Drugs and Therapy Perspectives 14, 11.

Dye, C., Scheele, S., Dolin, P., Pathania, V. & Raviglione, M.C. (1999). Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA 282, 677-686.

Netto, E., Dye, C. & Raviglione, M.C. (1999). Tuberculosis control 1995-97. Wkly Epidemiol.Rec. 74, 217-228.

Netto, E.M., Dye, C. & Raviglione, M.C. (1999). Progress in global tuberculosis control 1995-1996, with emphasis on 22 high-incidence countries. Global Monitoring and Surveillance Project. Int.J.Tuberc.Lung Dis. 3, 310-320.

Ogden, J., Rangan, S., Uplekar, M., Porter, J., Brugha, R., Zwi, A. & Nyheim, D. (1999). Shifting the paradigm in tuberculosis control: illustrations from India. Int.J.Tuberc.Lung Dis. 3, 855-861.

Zalesky, R., Abdullajev, F., Khechinashvili, G., Safarian, M., Madaras, T., Grzemska, M., Englund, E., Dittmann, S. & Raviglione, M. (1999). Tuberculosis control in the Caucasus: successes and constraints in DOTS implementation. Int.J.Tuberc.Lung Dis. 3, 394-401.
                                                                                                                   [top of list]

1998
Dye, C., Garnett, G.P., Sleeman, K. & Williams, B.G. (1998). Prospects for worldwide tuberculosis control under the WHO DOTS strategy. Directly observed short-course therapy. Lancet 352, 1886-1891.

Migliori, G.B. & Raviglione, M.C. (1998). Central and Eastern Europe. In Clinical Tuberculosis (Davies, P.D., ed.), Chapman and Hall Medical, London, pp. 643-660.

Norval, P.Y., San, K.K., Bakhim, T., Rith, D.N., Ahn, D.I. & Blanc, L. (1998). DOTS in Cambodia. Directly observed treatment with short-course chemotherapy. Int.J.Tuberc.Lung Dis. 2, 44-51.

Veen, J., Raviglione, M., Rieder, H.L., Migliori, G.B., Graf, P., Grzemska, M. & Zalesky, R. (1998). Standardized tuberculosis treatment outcome monitoring in Europe. Recommendations of a Working Group of the World Health Organization (WHO) and the European Region of the International Union Against Tuberculosis and Lung Disease (IUATLD) for uniform reporting by cohort analysis of treatment outcome in tuberculosis patients. Eur.Respir.J. 12, 505-510.
                                                                                                                   [top of list]

1997
Connolly, M.A., Chaulet, P. & Raviglione, M.C. (1997). Epidemiology of tuberculosis. In Tuberculosis (Wilson, R., ed.), European Respiratory Society, Sheffield, pp. 51-67.

Drobniewski, F., Pablos-Mendez, A. & Raviglione, M.C. (1997). Epidemiology of tuberculosis in the world. In: Heifets, L. (Ed.) Tuberculosis. Semin.Respir.Crit.Care Med. 18, 419-429.

Kochi, A., Nunn, P., Dye, C. & Tayler, E. (1997). Global burden of disease [letter]. Lancet 350, 142

Migliori, G.B. & Raviglione, M.C. (1997). Population surveillance and prevention strategies for tuberculosis. Annales Nestlé 55, 24-34.

Pio, A., Luelmo, F., Kumaresan, J. & Spinaci, S. (1997). National tuberculosis programme review: experience over the period 1990-95. Bull.World Health Organ. 75, 569-581.

Raviglione, M.C., Nunn, P.P., Johnson, M.A. & Miller, R.F. (1997). Epidemiology of tuberculosis. In AIDS and Respiratory Medicien (Zumla, A., ed.), Chapman & Hall Medical, London, pp. 117-141.

Raviglione, M.C., Dye, C., Schmidt, S. & Kochi, A. (1997). Assessment of worldwide tuberculosis control. WHO Global Surveillance and Monitoring Project. Lancet 350, 624-629.

Styblo, K. & Raviglione, M.C. (1997). Tuberculosis, public health aspects. In Encyclopedia of Human Biology (Dulbecco, R., ed.), Academic Press, Inc., SanDiego, CA, pp. 537-558.
                                                                                                                   [top of list]

WHO Documents (Epidemiology, Surveillance and Control): 2002/2001/2000/1999/1998/1997/1996/1995/1994/1993/1992/1991/1988
(for information on language(s) available, price where applicable and how to order, click here)

2004
WHO Report 2004.  Global Tuberculosis Control - Surveillance, Planning, Financing.  WHO/HTM/TB/2004.311.

2003
WHO Report 2003.  Global Tuberculosis Control - Surveillance, Planning, Financing.  WHO/CDS/TB/2003.316.

2002
WHO Report 2002.  Global Tuberculosis Control - Surveillance, Planning, Financing.  WHO/CDS/TB/2002.295.

2001
The use of indicators for communicable disease control.  2001.  
WHO/CDS/TB/2001.289 [pdf - 77KB].

WHO Report 2001.  Global Tuberculosis Control. WHO/CDS/TB/2000.287.

2000
WHO Report 2000.  Global Tuberculosis Control. WHO/CDS/TB/2000.275
                                                                                                                   [top of list]

1999
Status of tuberculosis in the 22 high-burden countries, 1999. WHO/CDS/CPC/TB/99.271 
[pdf - 4.3MB].

2nd Review of the National Tuberculosis Programme in Thailand, July 1999. WHO/CDS/TB/99.273 [pdf - 3.05MB].

Dye, C., et al. (1999). Global burden of tuberculosis: estimated incidence, prevalence and mortality by country in 1997 (published in JAMA 282:677-686, 1999). WHO/CDS/CPC/TB/99.264 [pdf - 2.17MB].

Maher, D. & Mikulencak, M. (1999). What is DOTS? - A guide to understanding the WHO-recommended TB control strategy known as DOTS. WHO/CDS/CPC/TB/99.270 [English, pdf - 740KB] [French, pdf - 305KB].

Salaniponi, F., et al. (1999). TB Research - Putting research into policy and practice: the experience of the Malawi National Tuberculosis Programme. WHO/CDS/CPC/TB/99.268.

World Health Organization (1999). Global Tuberculosis Control - WHO Report 1999. WHO/TB/99.259.  
                                                                                                                   [top of list]

1998
Chaulet, P., et al. (1998). Revue du programme national de lutte contre la tuberculose en Côte d'Ivoire, 4-20 juin 1997. WHO/TB/98.244.

Review of the national tuberculosis programme of Bangladesh, 16-28 November 1997. WHO/TB/98.238.

Status of tuberculosis in the 22 high-burden countries and global constraints to TB control. WHO/TB/98.242.

Report of the ad hoc committee on the tuberculosis epidemic, London, 17-19 March 1998. WHO/TB/98.245.

World TB Day 1998, Summary of events. WHO/TB/98.246.

Dye, C., et al. (1998). Prospects for global tuberculosis control under the WHO DOTS strategy. WHO/TB/98.251.

Kumaresan, J., Luelmo, F. & Smith, I. (1998). Guidelines for conducting a review of a national tuberculosis programme. WHO/TB/98.240.

Mikulencak, M., et al. (1998). TB: a crossroads - WHO report on the global tuberculosis epidemic 1998. WHO/TB/98.247.
                                                                                                                   [top of list]

Pio, A. & Chaulet, P. (1998). Tuberculosis handbook. WHO/TB/98.253 [pdf - 3.08MB].

Valway, S., et al. (1998). Tuberculosis and Air Travel: Guidelines for Prevention and Control. WHO/TB/98.256 .

World Health Organization (1998). Global Tuberculosis Control - WHO Report 1998. WHO/TB/98.237

1997
Revue du Programme National de Lutte Antituberculeuse de la République de Djibouti (PC/UG). WHO/TB/97.226.

Tuberculosis Control. The DOTS Strategy. (Directly Observed Treatment Short-Course) An annotated bibliography compiled by GTB & the Regional Office for South-East Asia (NPS). WHO/TB/97.228.

Chakraborty, AK. (1997). Prevalence and Incidence of Tuberculosis Infection and Disease in India: A Comprehensive Review by A.K. Chakraborty, Bangalore, India WHO/TB/97.231.

Chaulet, P. (1997). Revue du Programme National de lutte contre la Tuberculose au Mali. WHO/TB/97.235.

Klaudt, K. (1997). WHO Report on the Tuberculosis Epidemic 1997. Use Dots more widely. WHO/TB/97.224.

Raviglione, M. & Spinaci, S. (1997). Global Tuberculosis Control: WHO Report 1997. WHO/TB/97.225.  
                                                                                                                   [top of list]

1996
Tuberculosis Notification Update - February 1996, Global Tuberculosis Programme, WHO, Geneva (G.101). WHO/TB/96.197.

Groups at Risk, Annual Report 1996. WHO/TB/96.198.

Country Review - Guinée. WHO/TB/96.201.

Country Review - Mexico. WHO/TB/96.202.

Managing TB at National Level. WHO/TB/96.203

Country Review - Morocco. WHO/TB/96.206.

A Development Plan for the National Tuberculosis Control Programme - TB Control in Pakistan 1996/7 - 2000/1. WHO/TB/96.207.

Tuberculosis Control Programme Review - South Africa (English). WHO/TB/96.208.

Managing Tuberculosis on District Level. WHO/TB/96.211.

Programme Review: Nepal. WHO/TB/96.212.

Programme Review: India. WHO/TB/96.213.

Programme Review: Ethiopia. WHO/TB/96.214.
                                                                                                                   [top of list]

National Tuberculosis Programme Review: Experience in 12 Countries during the Period 1990-1995. WHO/TB/96.217.

Harrison, T. (1996). Tuberculosis Control in China - A Case Study of the Infectious and Endemic Disease Control Project (Tuberculosis Component). WHO/TB/96.215. 

1995
Tuberculosis Notification Update - December 1994, Tuberculosis Programme, WHO, Geneva (G.99). WHO/TB/95.182.

Stop TB at the Source - WHO Report on the Tuberculosis Epidemic, 1995, Tuberculosis Programme, WHO, Geneva. WHO/TB/95.183.

Country Review: Zimbabwe, Global Tuberculosis Programme, WHO, Geneva (NPS). WHO/TB/95.185.

Country Review: India, Global Tuberculosis Programme, WHO, Geneva (NPS). WHO/TB/95.186.

Country Review: Peru, Global Tuberculosis Programme, WHO, Geneva (NPS). WHO/TB/95.187.

Country Review: Indonesia, Global Tuberculosis Programme, WHO, Geneva (NPS). WHO/TB/95.188.

Country Review: Nepal, Global Tuberculosis Programme, WHO, Geneva (NPS). WHO/TB/95.189.

Country Review: Ethiopia, Global Tuberculosis Programme, WHO, Geneva (NPS). WHO/TB/95.190.
                                                                                                                   [top of list]

Country Review: Brazil, Global Tuberculosis Programme, WHO, Geneva (NPS). WHO/TB/95.191.

Country Review: Thailand, Global Tuberculosis Programme, WHO, Geneva (NPS). WHO/TB/95.192.

The Use of Restriction Fragement Length Polymorphism (RFLP) Analysis for Epidemiological Studies of Tuberculosis in Developing Countries. Report of a WHO Review and Planning Meeting, Geneva, 7-8 December 1994. Global Tuberculosis Programme, WHO, Geneva. (G.100). WHO/TB/95.194.

Tuberculosis Control in the Caucasus (A.75). WHO/TB/95.196. 

1994
Tuberculosis Notification Update - December 1993, Tuberculosis Programme, WHO, Geneva (G.97). WHO/TB/94.175.  

TB: A Global Emergency - WHO Report on the TB Epidemic, 1994, Tuberculosis Programme, WHO, Geneva (A.71). WHO/TB/94.177.

WHO Tuberculosis Programme: Framework for Effective Tuberculosis Control, WHO, Geneva. WHO/TB/94.179

Raviglione, M., et al. (1994). Tuberculosis Trends in Eastern Europe and the Former USSR, M. Raviglione, H. Rieder, K. Styblo, A. Khomenko, K. Esteves, A. Kochi (G.98). WHO/TB/94.176.
                                                                                                                   [top of list]

1993
Tuberculosis Control Programme - Cuba, 1992, Dr Rodolfo Rodriguez Cruz, Ministry of Health, Cuba (A.71). WHO/TB/93.172. 

Dolin, P., et al. (1993). A review of Current Epidemiological Data and Estimation of Future Tuberculosis Incidence and Mortality (G.96). WHO/TB/93.173.

1992
Tuberculosis Notification Update - July 1992, Tuberculosis Unit, WHO, Geneva (G.69). WHO/TB/92.169. 

1991
Report and Recommendations of WHO meeting: Tuberculosis control and research strategy for the 1990's (A.68). WHO/TB/91.157.

First programme report (1989-1990) and future plan (1991-1995): Global tuberculosis situation and tuberculosis control programme (A.69). WHO/TB/91.159.

Tuberculosis Surveillance and Monitoring: Report of a WHO meeting, Geneva, 20-22 March 1991 (G.95). WHO/TB/91.163.

Sudre, P., et al. (1991). Tuberculosis: A global overview of the situation today (G.94). WHO/TB/91.158.  
                                                                                                                   [top of list]

1988
The risk of tuberculosis infection in Tunisia, by Direction des Soins de Sant‚ de Base, Tunis (G.93). WHO/TB/88.155.

Cauthen, GM., et al. (1988). Annual risk of tuberculous infection (G.92). WHO/TB/88.154.

Leowski, J. (1988). The role of short-course chemotherapy in national tuberculosis control 0programmes in developing countries (E.62). WHO/TB/88.156.

Styblo, K. (1988). The national tuberculosis/leprosy programme in Tanzania (A.67). WHO/TB/88.153.  

Gender  WHO documents

back to top of the page
back to top

2001
Uplekar, M., Rangan S., Weiss, M.G., Ogden, J.  Attention to gender issues in tuberculosis control.  Int. J. Tuberc. Lung. Dis. 5(3):1-5.  2001 IUATLD.

2000
Borgdorff, M.W., Nagelkerke, N.J., Dye, C. & Nunn, P. (2000). Gender and tuberculosis: a comparison of prevalence surveys with notification data to explore sex differences in case detection. Int.J.Tuberc.Lung Dis. 4, 123-132.

1998
Rangan, S. & Uplekar, M. (1998). Gender perspectives of access to health and tuberculosis care. In Gender and Tuberculosis (Diwan, V., Thorson, A. and Winkvist, A., eds.), The Nordic School of Public Health, Göteborg.

Holmes, C.B., Hausler H. and Nunn P.  A review of sex differences in the epidemiology of tuberculosis [abstract].  Int J Tuberc Lung Dis 1998 Feb;2(2):96-104.

WHO Documents (Gender):
(for information on language(s) available, price where applicable and how to order, click here)

2000
Uplekar, M., Rangan, S., Ogden, J.  Gender and Tuberculosis Control:  Towards a strategy for research and action.  WHO/CDS/TB/2000.280 [Word - 183KB]

1999
Borgdorff, M. (1999). Gender and TB in Bangladesh: evidence for gender bias in TB case detection and proposals for further study. WHO/CDS/CPC/TB/99.266.

General

2003/2002/2001/1999/1998/1997/WHO Documents

back to top of the page
back to top

2003
Frieden, T.R., Sterling, T.R., Munsiff, S.S., Watt, C. & Dye, C.  (2003)  Seminar:  Tuberculosis.  Lancet 362, 887-899.

Blanc, L.., Uplekar, M. (contributors.)  The return of the white plague:  Global poverty and the "new" tuberculosis.  Edited by Matthew Gandy & Alimuddin Zumla. Verso 2003.  ISBN 1-85984-669-6

Proceedings from the 4th World Congress on Tuberculosis, Tuberculosis Volume 83, Issues 1-3, Pages 1-219 (2003).

2002
Raviglione, M.C., Pio, A (2002).  Evolution of WHO policies for tuberculosis control, 1948-2001.  The Lancet359:  775-780.

2001
O'Brien R and Nunn PP (2001) The need for new drugs against tuberculosis; obstacles, opportunities and next steps. Am J Respir Crit Care Med. 162: 1055-1058.

Nunn PP (2001) The global control of tuberculosis: what are the prospects? Scand J Infect Dis 33; 329-332

1999
Maher, D., Nunn P. (1999). Tuberculosis – problems and solutions: the global tuberculosis research initiative. RT International, 48-52.

Maher, D. (1999). The internationally recommended tuberculosis control strategy. Tropical Doctor. 29, 185-186.

1998
Maher, D., Nunn, P. (1998). Tuberculosis: an international perspective. Journal of the Royal College of Physicians. 32, 309-314.

Raviglione, M.C., Brien, R., Braunwald, E., Isselbacher, K.J., Wilson, J.D., Martin, J., Kasper, D., Hauser, S. & Longo, D. (1998). Chapter 171: Tuberculosis. In Harrison's Principles of Internal Medicine (Fauci, A.S., ed.), McGraw-Hill, New York, pp. 1004-1014.

1997
Maher, D., Kochi, A. (1997). Combating tuberculosis. RT International, 80-81.
                                                                                                                   [top of list]

WHO Documents (General):
(for information on language(s) available, price where applicable and how to order, click here)

2004
WHO/HTM/TB/2004.334

2003
Global Plan to Stop TB.  WHO/CDS/STB/2003.23.  English [pdf-153KB],  French [pdf-157KB],  Spanish [pdf-156KB].

2002
Guidelines for cost and cost-effectiveness of TB Control.  Parts 1 (CDS/TB/2002.305a), 2 (CDS/TB/2002.305b) and 3 (CDS/TB/2002.305c).  

Stop TB Annual Report 2001.  WHO/CDS/STB/2002.17 [pdf - 423KB].

2001
Pinet, G. (2001) 
Good practice in legislation and regulations for TB control:  An indicator of political will.  WHO/CDS/TB/2001.290 [pdf - 163KB].

World Health Organization (2001) SEARO. Tuberculosis Control, an Annotated Bibliography. SEA/TB/233 [pdf - 139KB]. 

1998
Nunn, P. & Linkins, J. (1998). The Global Tuberculosis Research Initiative: research to make a difference, Geneva, February 1998. WHO/TB/98.248 [pdf - 1.20MB].

Klaudt, K. & Owens, B.  TB advocacy - A practical guide 1999.  (English/French/Spanish).  WHO/TB/98.239 [html] or pdf [8MB]

1991
Tuberculosis Research and Development, Report of a WHO Meeting, Geneva, 24-25 October 1990, (B.12). WHO/TB/91.160 [pdf - 1.2MB].

Tuberculosis Research and Development: Report of a WHO Working Group meeting, Geneva, 9-11 September 1991 (B.13). WHO/TB/91.162 [pdf - 1.1MB].
                                                                                                                   [top of list]

Global Drug Facility
WHO documents

back to top of the page
back to top

WHO Documents (Global Drug Facility):
(for information on language(s) available, price where applicable and how to order, click here)

2002
Frequently asked questions about the 4-drug fixed-dose combination tablet recommended by WHO for treating tuberculosis. 
WHO, Stop TB Partnership.  WHO/CDS/STB/2002.18 
[pdf - 164KB]

Health and Safety
1999/1998/1997/1996/WHO documents

back to top of the page
back to top

1999
Harries, A.D., Nyirenda, T.E., Banerjee, A., Boeree, M.J. & Salaniponi, F.M. (1999). Tuberculosis in health care workers in Malawi. Trans.R.Soc.Trop.Med.Hyg. 93, 32-35.

1998
Nyirenda, T.E., Mundy, C.J., Harries, A.D., Banerjee, A. & Salaniponi, F.M. (1998). Safety in laboratories carrying out sputum smear microscopy: a dilemma for resource-poor countries. Int.J.Tuberc.Lung Dis. 2, 690-693.

1997
Harries, A.D., Maher, D., Nunn, P. (1997). Practical and affordable measures for the protection of health workers from tuberculosis in low-income countries. Bull.World Health Organ. 75, 477-489.

Harries, A.D., Maher, D., Nunn, P. (1997). Practical and affordable measures for the protection of health workers from tuberculosis in low-income countries. Bull.World Health Organ. 75, 477-489.

1996
Raviglione, M.C., Grzemska, M., Alisherov, A.S. & Limarev, P.I. (1996). Tuberculosis control in Kyrgyzstan--an opportunity. World Health Forum 17, 85-90.
                                                                                                                   [top of list]

WHO Documents (Health and Safety):
(for information on language(s) available, price where applicable and how to order, click here)

1999
Espinal, M. (1999). Guidelines for the prevention of tuberculosis in health care facilities in resource-limited settings. WHO/CDS/TB/99.269.

M. bovis

back to top of the page
back to top

2004
Godfray, C.J., 
Curnow, R.N.Dye, C.,  Pfeiffer, D.,  Sutherland, W.J.,  Woolhouse, M.F.J.  Independent Scientific Review of the Randomised Badger Culling Trial and Associated Epidemiological Research.  Report to Mr Ben Bradshaw MP, 4th March 2004.  Read more.  Download pdf [364KB].

1998
Cosivi, O., Grange, J.M., Daborn, C.J., Raviglione, M.C., Fujikura, T., Cousins, D., Robinson, R.A., Huchzermeyer, H.F., de Kantor, I. & Meslin, F.X. (1998). Zoonotic tuberculosis due to Mycobacterium bovis in developing countries. Emerg.Infect.Dis. 4, 59-70.

Operational Issues & Training
2000/1999/1998/1996/WHO documents

back to top of the page
back to top

2000
Banerjee, A., Harries, A.D., Mphasa, N., Nyirenda, T.E., Veen, J., Ringdal, T., Van, G.J. & Salaniponi, F.M. (2000). Evaluation of a unified treatment regimen for all new cases of tuberculosis using guardian-based supervision. Int.J.Tuberc.Lung Dis. 4, 333-339.

1999
Blomberg, B., Kitler, M.E., Milstien, J., Dellepiane, N., Fanning, A., Norval, P.Y. & Spinaci, S. (1999). Availability of quality fixed-dose combinations for the treatment of tuberculosis: what can we learn from studying the World Health Organization's vaccine model? Int.J.Tuberc.Lung Dis. 3, S371-S380.

Migliori, G.B., Raviglione, M.C., Schaberg, T., Davies, P.D., Zellweger, J.P., Grzemska, M., Mihaescu, T., Clancy, L. & Casali, L. (1999). Tuberculosis management in Europe. Task Force of the European Respiratory Society (ERS), the World Health Organisation (WHO) and the International Union against Tuberculosis and Lung Disease (IUATLD) Europe Region. Eur.Respir.J. 14, 978-992.
                                                                                                                   [top of list]

Uplekar, M., Walley, J. & Newell, J. (1999). Directly observed treatment for tuberculosis. Lancet 353, 145-145.

1998
Harries, A.D., Banda, H.T., Boeree, M., Welby, S., Wirima, J.J., Subramanyam, V.R., Maher, D., Nunn, P. (1998). Management of pulmonary tuberculosis suspects with negative sputum smears and normal or minimally abnormal chest radiographs in resource-poor settings. International Journal of Tuberculosis and Lung Disease. 2, 999-1004.

Nyirenda, T., Harries, A.D., Banerjee, A. & Salaniponi, F.M. (1998). Registration and treatment of patients with smear-positive pulmonary tuberculosis [letter]. Int.J.Tuberc.Lung Dis. 2, 944-945.

Nyirenda, T.E., Gaisu, F.K. & Salaniponi, F.M. (1998). History-taking in tuberculosis suspects at Likuni Hospital in Malawi. Malawi Med.J. 14, 60-61.

1996
Raviglione, M.C., Grzemska, M., Alisherov, A.S. & Limarev, P.I. (1996). Tuberculosis control in Kyrgyzstan--an opportunity. World Health Forum 17, 85-90.
                                                                                                                   [top of list]

WHO Documents (Operational Issues and Training)1999/1998/1997/1996/1992
(for information on language(s) available, price where applicable and how to order, click here)

1999
Salaniponi, F., et al. (1999). TB Research - Putting research into policy and practice: the experience of the Malawi National Tuberculosis Programme. WHO/CDS/CPC/TB/99.268.

1998
Pio, A. & Chaulet, P. (1998). Tuberculosis handbook. WHO/TB/98.253.

1997
Tuberculosis Control in Refugee Situations: An Interagency Field Manual. WHO/TB/97.221 
[pdf - 284KB].

Bhatnagar, D. & Almeida, J. (1997). Factors Influencing the Perceived Priority of TB in India. WHO/TB/97.234 [pdf - 1.3MB]

Pio, A. & Chaulet, P. (1997). Standardization of District-Based Packages of Care for the Management of Tuberculosis and other Respiratory Diseases among Youth and Adults. WHO/TB/97.232 [pdf - 1.5MB]

Ravichandran, N. & Almeida, J. (1997). India: RNTCP. Logistics and Distribution of Drugs. WHO/TB/97.230 [pdf - 921KB].
                                                                                                                   [top of list]

1996
Managing TB at National Level. WHO/TB/96.203.

Managing Tuberculosis on District Level. WHO/TB/96.211.

1992
Guide technique pour les personnels de Santé, Programme national de lutte anti-tuberculeuse dans la République de Guinée, par le Ministère de la Santé publique et de la Population, Conakry en collaboration avec l'Organisation mondiale de la Santé (N.1). WHO/TB/92.165.

Weil, D. (1992). Issues in anti-tuberculosis drug supply (M.1). WHO/TB/92.164.

Practical Approach to Lung Health (PAL)

back to top of the page
back to top

WHO Documents:
(for information on language(s) available, price where applicable and how to order, click here)

2004
PAL - Respiratory Care in Primary Care Services - A Survey in 9 Countries
WHO/HTM/TB/2004.333 [pdf - 5.5MB].

2003
PAL - Practical Approach to Lung Health - Leaflets.  (2003)  [pdf - 170KB]

Report of the First International Review Meeting - Practical Approach to Lung health strategy, Rabat, 4-6 September 2002.  WHO/CDS/TB/2003.324 [pdf - 158KB]

2002

Guide pratique pour la prise en charge des malades ayant des symptômes respiratoires dans les formations sanitaires de base au Maroc.  WHO/CDS/TB/2002.298a [pdf - 400KB].

Guide pratique pour la prise en charge des maladies respiratoires dans les services de santé publiques spécialisés du Maroc.  WHO/CDS/TB/2002.298b [pdf - 446KB].

Prise en charge combinée des maladies respiratoires et de la tuberculose au Maroc.  WHO/CDS/TB/2002.298c [pdf - 30KB].

1998
Scherpbier, R., Hanson, C. & Raviglione, M. (1998). The Adult Lung Health Initiative - Report - Geneva, 4-15 May 1998. WHO/TB/98.257.

Prisoners & Refugees

back to top of the page
back to top

2000
Coninx, R., Maher, D., Reyes, H. & Grzemska, M. (2000). Tuberculosis in prisons in countries with high prevalence. BMJ 320, 440-442.

1997
Nyangulu, D.S., Harries, A.D., Kang'ombe, C., Yadidi, A.E., Chokani, K., Cullinan, T., Maher, D., Nunn, P., Salaniponi, F.M. (1997). Tuberculosis in a prison population in Malawi. Lancet. 350, 1284-1287.

WHO Documents (Prisoners & Refugees):
(for information on language(s) available, price where applicable and how to order, click here)

2001
Bone, A., Aertts, A., Grzemska, M et al. (2001). Tuberculosis control in prisons - a manual for Programme Managers. WHO/CDS/TB/2000.281.  
English - html and pdf - 2197KB ;  
Spanish
[pdf - 1875KB];  Russian [pdf - 891KB]

1998
Maher, D., Grzemska, M., Coninx, R., Reyes, H. (1998). Guidelines on the control of tuberculosis in prisons. World Health Organization and International Committee of the Red Cross. WHO/TB/98.250 (English and Russian) - Now OUT OF DATE.

1997
WHO/UNHCR. 
Tuberculosis Control in Refugee Situations: An Interagency Field Manual.  WHO/TB/97.221  English [pdf - 284KB];  FrenchRussian  [pdf - 609KB]

1996
Tuberculosis Control in Refugees and Displaced Persons. WHO/TB/96.209.
                                                                                                                   [top of list]

Private/Public Mix
2003/2001/1999/1998//WHO documents

back to top of the page
back to top

2003
Uplekar, M. (2003) Involving private health care providers in delivery of TB care: global strategy. Tuberculosis. 83, 156-164.  [pdf - 97KB]

2001
Barry C, Cole S, Fourie B, Geiter L, Gosey L, Grosset J, Kanyok T, Laughon B, Mitchison D, Nunn P, O'Brien R, Robinson T. (2001) Scientific blueprint for anti-TB drug development. Tuberculosis, 81; (supplement 1) 1-52.

1999
Uplekar, M. (1999). Involving the private medical sector in tuberculosis control. In Tuberculosis: An International Perspective (Porter, J.D.H. and Grange, J.M., eds.), Imperial College Press, London.

1998
Uplekar, M., Juvekar, S., Morankar, S., Rangan, S. & Nunn, P. (1998). Tuberculosis patients and practitioners in private clinics in India. Int.J.Tuberc.Lung Dis. 2, 324-329.

WHO Documents (Private/Public Mix):  2003/2001/1997
(for information on language(s) available, price where applicable and how to order, click here)

2004
Public-Private Mix for DOTS.  Global Progress.  Report of the Second Meeting of the PPM Subgroup for DOTS Expansion.  WHO/HTM/TB/2004.338 [pdf - 3.5MB].

Cost and cost-effectiveness of Public-Private Mix DOTS:  Evidence from two pilot projects in India
WHO/HTM/TB/2004.337 [pdf - 3.5MB]

2003
Public-private mix DOTS in Indonesia - A strategy for action.  
WHO/CDS/TB/2003.326
[pdf - 3593KB]

Public-Private Mix for DOTS - Practical tools to help implementation.  WHO/CDS/TB/2003.325 [pdf - 1889KB]

First meeting of the Public-Private Mix - Subgroup for DOTS Expansion.  WHO/CDS/TB/2003.317  [pdf - 675KB]

2001
Uplekar, M., Pathania, V., Raviglione, M. (2001). Involving Private Practitioners in Tuberculosis Control: Issues, Interventions, and emerging policy framework. WHO/CDS/TB/2001.285.

1997
The Behaviour and Interaction of TB Patients and Private For-Profit Health Care Providers in India: A Review (Out of Print). WHO/TB/97.223 [pdf - 6.5MB].

Ramana, GNV. (1997). Mapping of TB Treatment Providers at Selected Sites in Andhra Pradesh State, India. WHO/TB/97.233 [pdf - 822KB].
                                                                                                                   [top of list]

 

Research

back to top of the page
back to top

2002
Nunn, P., Harries, A., Godfrey-Faussett, P., Gupta, R., Maher, D., Raviglione M.  The research agenda to improve health policy, systems performance and service delivery in tuberculosis: a World Health Organization perspective.  Bulletin of the World Health Organization 2002; 80: 471-476.

 

TB/HIV
 
2004/2003/2002/2001/2000/1999/1998/1997/WHO documents

back to top of the page
back to top

2004
Corbett, E.L., Charalambous, S., Moloi, V.M., Fielding, K., Grant, A.D., Dye, C., De Cock, K.M., Hayes, R.J., Williams, B.G. & Churchyard, G.J. (2004) Human immunodeficiency virus and the prevalence of undiagnosed tuberculosis in African gold miners. American Journal of Respiratory and Critical Care Medicine.
2004 Sep 15;170(6):673-9 (e-pub June 10).

2003
Korenromp, E.L., Scano, F., Williams, B.G., Dye, C., Nunn, P.  Reply to letter:  "Infection with Hepatitis C Virus Transmitted by Accidental Needlesticks".  Clin Infect Dis. 2003 Dec 15; 37(12):1720-2.

Currie, S.M., Williams, B.G., Cheng, R.C.H. and Dye, C.  Tuberculosis epidemics driven by HIV: is prevention better than cure?  AIDS 2003, 17:2501–2508.  (Supplementary material - pdf-57KB)

Williams, B.G., & Dye, C.  (2003)  Antiretroviral drugs for tuberculosis control in the era of HIV/AIDS.  Science 301, 1535-1537.

Korenromp, E.L., Scano, F., Williams, B.G., Dye, C., Nunn, P., Communicable Diseases, Stop TB Department, World Health Organization, Geneva, Switzerland.  Effects of human immunodeficiency virus infection on recurrence of tuberculosis after rifampin-based treatment: an analytical review.    Clin Infect Dis. 2003 Jul 1;37(1):101-12. Epub 2003 Jun 23.  
[download pdf -   261KB]

Corbett, Elizabeth L., Watt, Catherine J., Walker, Neff, Maher, Dermot, Williams, Brian G., Raviglione, Mario C., Dye, Christopher.  The Growing Burden of Tuberculosis:  Global Trends and Interactions with the HIV Epidemic.  Arch Intern Med. 2003;163:1009-1021.  (full article)

2002
Godfrey-Faussett P, Maher D, Mukadi YD, Nunn P, Perriëns J, & Raviglione MHow human immunodeficiency virus voluntary testing can contribute to tuberculosis control.  Bulletin of the World Health Organization,
December 2002, Volume 80, Number 12 (939-945)  [PDF - 322KB] 

2001
Dye, C. & Nagelkerke, N.J.D. (2001) Potential impact of tuberculosis control, with implications for HIV/AIDS. Ch. 4 In: Vinokur, A., Godinho J., Dye, C. & Nagelkerke, N. The TB and HIV/AIDS Epidemics in the Russian Federation. World Bank Technical Paper No. 510. World Bank, Washington D.C.

Harries AD, Hargreaves NJ, Kemp J, Jindani A, Enarson DA, Maher D, Salaniponi FM.  Deaths from tuberculosis in sub-Saharan African countries with a high prevalence of HIV-1. Lancet 2001; 357: 1519-23.

Ya Diul M, Maher D, Harries A.  Tuberculosis case fatality rates in high HIV prevalence populations in sub-Saharan Africa.  AIDS 2001; 15: 143-152.

2000
Banda H, Kang’ombe C, Harries AD, Nyangulu D, Whitty CM, Wirima JJ, Salaniponi FM, Maher D, Nunn P. (2000) Mortality rates and recurrent rates of tuberculosis in patients with smear-negative pulmonary tuberculosis and tuberculous effusion who have completed treatment. Int J Tub Lung Dis. 4; 968-974.

Espinal, M.A., Peréz, E.N., Baéz, J., Henriquez, L., Fernandez, K., Lopez, M., Olivo, P. & Reingold, A.L. (2000). Infectiousness of Mycobacterium tuberculosis in HIV-1-infected patients with tuberculosis: a prospective study. Lancet 355, 275-280.

Kang’ombe C, Harries A, Banda H, Nyangulu D, Whitty C, Salaniponi FM, Maher D, Nunn P.  High mortality rates in tuberculosis patients in Zomba Hospital, Malawi, during 32 months of follow-up.  Trans Roy Soc Trop Med Hyg 2000; 94: 305-309.

1999
Floyd, K., Reid, R.A., Wilkinson, D. & Gilks, C.F. (1999). Admission trends in a rural South African hospital during the early years of the HIV epidemic. JAMA 282, 1087-1091.

Harries, A.D., Banda, H.T., Banda, G., Salaniponi, F.M., Maher, D., Nunn, P. (1999). Prevalence of sexually transmitted diseases in tuberculosis patients in Malawi. Trop.Doct. 29, 55-56.

Maher, D. Smear-positive pulmonary tuberculosis: good clinical management is good public health. Africa Health (1999). 21, 6-9.

1998
Gilks, C.F., Floyd, K., Otieno, L.S., Adam, A.M., Bhatt, S.M. & Warrell, D.A. (1998). Some effects of the rising case load of adult HIV-related disease on a hospital in Nairobi. J.Acquir.Immune.Defic.Syndr.Hum.Retrovirol. 18, 234-240.

Harries, A.D., Nyirenda, T., Banerjee, A., Salaniponi, F.M. & Boeree, M.J. (1998). Tuberculosis control in the face of the HIV epidemic. Trop.Doct. 28, 243-245.

Harries, A.D., Maher, D., Nunn, P. (1998). An approach to the problems of diagnosis and treatment of adult smear-negative pulmonary tuberculosis in high HIV prevalence settings in sub-Saharan Africa. Bull.World Health Organ. 76, 651-662.
                                                                                                                   [top of list]

Harries, A.D., Nyangulu, D.S., Kang'ombe, C., Ndalama, D., Glynn, J.R., Banda, H., Wirima, J.J., Salaniponi, F.M., Liomba, G., Maher, D., Nunn, P. (1998). Treatment outcome of an unselected cohort of tuberculosis patients in relation to human immunodeficiency status in Zomba Hospital, Malawi. Trans.Roy.Soc.Trop.Med. Hyg. 92, 343-347.

Sawert, H., Girardi, E., Antonucci, G., Raviglione, M.C., Viale, P. & Ippolito, G. (1998). Preventive therapy for tuberculosis in HIV-infected persons: analysis of policy options based on tuberculin status and CD4+ cell count. Gruppo Italiano di Studio Tubercolosi e AIDS (GISTA). Archives of Internal Medicine 158, 2112-2121.

1997
Girardi, E., Antonucci, G., Ippolito, G., Raviglione, M.C., Rapiti, E., Di Perri, G. & Babudieri, S. (1997). Association of tuberculosis risk with the degree of tuberculin reaction in HIV-infected patients. The Gruppo Italiano di Studio Tubercolosi e AIDS. Archives of Internal Medicine 157, 797-800.

Harries, A.D., Nyangulu, D.S., Kangombe, C., Ndalama, D., Wirima, J.J., Salaniponi, F.M., Liomba, G., Maher, D., Nunn, P. (1997). The scourge of HIV-related tuberculosis: a cohort study in a district general hospital in Malawi. Ann.Trop.Med.Parasitol. 91, 771-776.

Raviglione, M.C., Harries, A.D., Msiska, R., Wilkinson, D. & Nunn, P. (1997). Tuberculosis and HIV: current status in Africa. AIDS 11, S115-S123
                                                                                                                   [top of list]

WHO Documents (TB/HIV):  2004/2003/2002/2001/1998/1996/1995/1994/1992
(for information on language(s) available, price where applicable and how to order, click here)

2004
A guide to monitoring and evaluation for collaborative TB/HIV activities WHO/HTM/TB/2004.242 (WHO/HTM/HIV/2004.09) [pdf - 726kb]

Guidelines for HIV surveillance among tuberculosis patients.  Second edition. WHO/HTM/TB/2004.339 [pdf - 586KB]

TB/HIV: A Clinical Manual.  2nd edition.  WHO/HTM/TB/2004.329 [pdf - 744KB].

Report of a "Lessons Learnt" Workshop on the six ProTEST pilot projects in Malawi, South Africa and Zambia, Durban, S. Africa, 3-6 February 2004.  WHO/HTM/TB/2004.336 [pdf - 175KB]

Interim policy on collaborative TB/HIV activities.  WHO/HTM/TB/2004.330 (WHO/HTM/HIV/2004.1) [pdf - 391KB].

2003
Report of the Third TB/HIV Working Group Meeting, 4-6 June 2003, Montreux.  WHO/CDS/TB/2003.327 [pdf - 231KB].

Stop TB Partnership:  Working Group on TB/HIV.  Guidelines for implementing collaborative TB and HIV programme activities.  WHO/CDS/TB/2003.319 (pdf - 300KB).

Second meeting of the global working group on TB/HIV, 14-16 June 2002, Durban, South Africa.  WHO/CDS/TB/2003.311 (pdf - 219KB).

2002
Maher D, Floyd K, Raviglione M.  A strategic framework to decrease the burden of TB/HIV.  English, French and Portuguese.  WHO/CDS/TB/2002.296

2001
Anderson SR, Maher D.  An analysis of interaction between TB and HIV/AIDS programmes in sub-Saharan Africa. (WHO/CDS/TB/2001.294 - available as PDF or Word document)

Bertherat E, Maher D, Bosman M, Nkhoma W, Gilks C, Godfrey-Faussett P.  Report on the first meeting of the Global Working Group on TB/HIV, 9-11 April 2001. (WHO/CDS/TB/2001.293
available as PDF or Word document)

1998
Managing the dual epidemics of tuberculosis and HIV/AIDS - A review of challenge and response in five countries: Brazil, India, Indonesia, Kenya, Thailand, March 1998. WHO/TB/98.243 English.

Godfrey-Fausset, P. (1998). Policy Statement on Preventive Therapy Against Tuberculosis in People Living with HIV - Report of a meeting held in Geneva 18-20 February 1998. WHO/TB/98.255; UNAIDS/98.34.
                                                                                                                   [top of list]

1996
A Deadly Partnership, Tuberculosis in the Era of HIV. WHO/TB/96.204.

Harries, A.D., Maher, D. (1996). TB/HIV: A Clinical Manual. WHO/TB/96.200.

1995
Tuberculosis and HIV Research: Working Towards Solutions, Results of a WHO Workshop on the Formulation of a New TB/HIV Research Strategy. Global Tuberculosis Programme, WHO, Geneva, 29-31 May 1995. (L.8). WHO/TB/95.193.

1994
Guidelines for HIV Surveillance among Tuberculosis Patients, Tuberculosis Programme, WHO, Geneva (L.7). WHO/TB/94.180.

1992
Tuberculosis/HIV Research: Report of a WHO Review and Planning Meeting, Geneva, 24-26 February 1992 (L.4). WHO/TB/92.167.

Narain, J., et al. (1992). HIV-associated tuberculosis in developing countries: epidemiology and strategies for prevention, J. Narain, M. Raviglione and A. Kochi(L.2). WHO/TB/92.166.
                                                                                                                   [top of list]

Training

back to top of the page
back to top

WHO Documents:  2004/2003/2002/1999/1998
(for information on language(s) available, price where applicable and how to order, click here)

2004
Management of Tuberculosis Training for Health Facility StaffHow to organize training for health facility staff on TB control WHO/HTM/TB/2004.332 [pdf - 471KB].

2003
Management of Tuberculosis - Training for health facility staff.  Modules A-J, Facilitator Guide and Answer Book.  Karin Bergström et al.   WHO/CDS/TB/2003.314

Training modules: managing TB at district level.  (Борьба с туберкулезом на уровне района)  Modules 1-14.  Russian and English.  WHO/CDS/TB/2002.310

2002
Training for better TB control:  Human resource development for TB control - A strategic approach within country support.  Karin Bergström et al.  WHO/CDS/TB/2002.301 English [pdf - 139KB], 
French [pdf - 169KB].

A guide for tuberculosis treatment supporters.  Munz M, Bergström K, et al.   WHO/CDS/TB/2002.300 - in English, French, Spanish and Portuguese.

1999
Tuberculose - Manuel pour les étudiants en médecine. WHO/CDS/TB/99.272.

1998
Chaulet, P. & Campbell, I. (1998). Tuberculosis control and medical schools - Report of a WHO workshop - Rome, 29-31 October 1997. WHO/TB/98.236.

Treatment and Treatment Outcomes
2003/2002/ 1999/1998/WHO documents

back to top of the page
back to top

2003
Espinal M.  Time to abandon the standard re-treatment regimen with first-line drugs for failures of the standard treatment.  Int J Tuberc Lung Dis 2003; 7:607-608.

2002
Harries, A.D., Hargreaves, N.J., Graham, S.M., Mwansambo, C., Kazembe, P., Broadhead, R., Maher, D., Salaniponi, F.M.  Childhood tuberculosis in Malawi: nationwide case-finding and treatment outcomes.  International Journal of Tuberculosis and Lung Disease 2002; 6(5):424-431.

1999
Blomberg, B., Maher, D., Spinaci, S., (1999). Rational use of drugs in the treatment of tuberculosis. In: Chaudhury R (ed): International experience in rational use of drugs. Volume 3. Bangkok, UNESCO.

Harries, A., Nyirenda, T., Banerjee, A., Boeree, M. & Salaniponi, F. (1999). Treatment outcome of patients with smear-negative pulmonary TB in the National Tuberculosis Control Programme, Malawi. Trans.R.Soc.Trop.Med.Hyg. 93, 443-446.

Harries, A.D., Chilemba, P.E., Greya, D., Nyirenda, T.E., Banerjee, A. & Salaniponi, F.M. (1999). Monitoring rifampicin compliance by visual inspection of urine colour. Trop.Doct. 29, 243-244.

Harries, A.D., Nyangulu, D.S., Banda, H., Kang'ombe, C., Van der Paal, L., Glynn, J.R., Subramanyam, V.R., Wirima, J.J., Salaniponi, F.M., Maher, D., Nunn, P. (1999). Efficacy of an unsupervised ambulatory treatment regimen for smear-negative pulmonary tuberculosis and tuberculous pleural effusion in Malawi. Int.J.Tuberc.Lung Dis. 3, 402-408.

Maher, D. Smear-positive pulmonary tuberculosis: good clinical management is good public health.  Africa Health. 21, 6-9.  (1999).

Migliori, G.B., Ambrosetti, M., Besozzi, G., Casali, L. & Raviglione, M.C. (1999). Prospective multicentre study on the evaluation of antituberculosis treatment results in Italy: comparison of the culture- versus the smear-based methods. National AIPO Tuberculosis Study Group. Eur.Respir.J. 13, 900-903.

Migliori, G.B., Raviglione, M.C., Schaberg, T., Davies, P.D., Zellweger, J.P., Grzemska, M., Mihaescu, T., Clancy, L. & Casali, L. (1999). Tuberculosis management in Europe. Task Force of the European Respiratory Society (ERS), the World Health Organisation (WHO) and the International Union against Tuberculosis and Lung Disease (IUATLD) Europe Region. Eur.Respir.J. 14, 978-992.

1998
Grosset, J., Lounis, N., Truffot-Pernot, C., Brien, R., Raviglione, M.C. & Ji, B. (1998). Once-weekly rifapentine-containing regimens for treatment of tuberculosis in mice. Am.J.Respir.Crit.Care Med. 157, 1436-1440.


                                                                                                                   [top of list]

WHO Documents (Treatment and Treatment Outcomes):  2002/2002/1999/1997/1996/1992/1991/1988 
(for information on language(s) available, price where applicable and how to order, click here)

2003
Treatment of Tuberculosis guidelines for national programmes - Third edition (in English).  The second edition exists in French and Spanish - these will be updated in due course.
WHO/CDS/TB/2003.313.

2002
Operational Guide for National Tuberculosis Control Programmes on the Introduction and Use of Fixed-Dose Combination Drugs WHO/CDS/TB/2002.308 (WHO/EDM/PAR/2002.6) - English
[pdf-507KB],
Russian [pdf - 1.6MB].

Blomberg B, Evans P, Phanouvong S, Nunn P. Informal consultation on 4-drug fixed-dose combinations compliant with the WHO model list of essential drugs. Geneva, World Health Organization, 2002, document TDR/TB/02.1, WHO/CDS/TB/2002.299 [pdf - 435KB]

1999
Ellard, G., et al. (1999). Establishing the bioequivalence of RIFAMPICIN in fixed-dose formulations containing isoniazid with or without Pyrazinamide and/or Ethambutol compared to the single drug reference preparations administered in loose combination, Model Protocol, 1999. WHO/CDS/TB/99.274 [pdf - 1560KB]

Laing, R., et al. (1999). Fixed-dose combination tablets for the treatment of tuberculosis - Report of an informal meeting, Geneva, 27 April 1999. WHO/CDS/CPC/TB/99.267.

1997
Maher, D., et al. (1997). Treatment of Tuberculosis, Guidelines for National TB Programmes. WHO/TB/97.220.  English version is now REPLACED BY 3rd EDITION (2003).  French and Spanish will be translated in due course. 
WHO/CDS/TB/2003.313

1996
Tuberculosis Control Workshop Report, Geneva, October 1995 and Revision of "Treatment of Tuberculosis: Guidelines for National Programmes". WHO/TB/96.199.

1992
Tuberculosis treatment guidelines for national tuberculosis programmes (E.65) No longer available for distribution - superseded by publication ISBN 92 4 1544511 Treatment of Tuberculosis - Guidelines for National Programmes. WHO/TB/92.168.

1991
Guidelines for tuberculosis treatment in adults and children in National Tuberculosis Programmes (E.63) No longer available for distribution - superseded by publication ISBN 92 4 1544511 Treatment of Tuberculosis - Guidelines for National Programmes. WHO/TB/91.161.

1988
Leowski, J. (1988). The role of short-course chemotherapy in national tuberculosis control programmes in developing countries (E.62). WHO/TB/88.156.
                                                                                                                   [top of list]

Vaccines

back to top of the page
back to top

Dye, C. (2004). A booster for tuberculosis vaccines.  JAMA, 291(17):2127-2128.

 


Catalogue of WHO TB Documents
References by Subject
Medline search by WHO author


 

 

 

 WHO Home - TB HomeWHO Search - Contact